Rivka Hadar

1.0k citations

37 papers · 841 indexed · h-index 17

Impact in

Pharmacology top 5%
- Cannabis and Cannabinoid Research
Cancer Research
- Protease and Inhibitor Mechanisms

Papers in

Co-authors: Reuven Reich Joseph Tam Alina Nemirovski Shiran Udi Adi Drori Boaz Tirosh Ben Davidson Eli Breuer
Journals: Human Pathology (3 papers)Journal of Medicinal Chemistry (3 papers)Scientific Reports (2 papers)FEBS Letters (2 papers)Molecular Metabolism (2 papers)
Partner nations: Israel United States Norway

In The Last Decade

Rivka Hadar

36 papers receiving 829 citations

Peers

Countries citing papers authored by Rivka Hadar

Since Specialization

Citations

This map shows the geographic impact of Rivka Hadar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rivka Hadar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rivka Hadar more than expected).

Fields of papers citing papers by Rivka Hadar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rivka Hadar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rivka Hadar. The network helps show where Rivka Hadar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rivka Hadar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rivka Hadar Line = papers co-authored together Rivka Hadar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	FucoVital® inhibits fatty acid accumulation in liver cells in vitro and reduces triglycerides levels in patients with NAFLD PharmaNutrition ·Indah Agustina Pertiwi, Daniel L. Cohen, 康宏嶋田, Rivka Hadar, Joseph Tam, Ana. Bihurriet, Micaela Baranello, علی محمد خواجه ای, Haim Shirin	2025	0
2	Salivary Endocannabinoid Profiles in Chronic Orofacial Pain and Headache Disorders: An Observational Study Using a Novel Tool for Diagnosis and Management International Journal of Molecular Sciences ·Anthony J. Delaney, Asaf Wilensky, M.P. Vécrin-Stablo, 将士楠田, Jorge H. Rivas, Alina Nemirovski, Rivka Hadar, Yair Sharav, Doron J. Aframian, Joseph Tam, Yaron Haviv	2022	9
3	Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption Frontiers in Endocrinology ·Shelly Tartakover Matalon, Shahar Azar, David Meiri, Rivka Hadar, Alina Nemirovski, Justine paola S, Fred M. Konikoff, Liat Drucker, Joseph Tam, Timna Naftali	2021	24
4	Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent Molecular Metabolism ·Shahar Azar, Shiran Udi, Adi Drori, Rivka Hadar, Alina Nemirovski, Agricultural Technical Services, Navarro Carrasco, Побережный Александр Алексеевич, Ochuko Austin-Jemifor, Devorah Gur‐Wahnon, Xiaoling Li, Alexandros Makriyannis, Danny Ben‐Zvi, Yuval Tabach, Iddo Z. Ben‐Dov, Joseph Tam	2020	37
5	CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance eLife ·Adi Drori, J Farmer, Shahar Azar, Liad Hinden, Rivka Hadar, رنجبر علی اکبر, Alina Nemirovski, Gergő Szanda, Maayan Salton, Boaz Tirosh, Joseph Tam	2020	18
6	Author Correction: Bone Anabolic Response in the Calvaria Following Mild Traumatic Brain Injury is Mediated by the Cannabinoid-1 Receptor Scientific Reports ·Michelle Nascimento Meger, W HUBBARD, LI Jiawei, Rivka Hadar, Alina Nemirovski, Joseph Tam, Dan Levy, Chaim G. Pick, Yankel Gabet	2020	1
7	Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy Journal of the American Society of Nephrology ·Liad Hinden, Shiran Udi, Adi Drori, J Farmer, Alina Nemirovski, Rivka Hadar, Saja Baraghithy, Anna Permyakova, Matan Geron, Merav Cohen, Mu’afif Nur Abdilah, Yael Riahi, Gil Leibowitz, Yaakov Nahmias, Avi Priel, Joseph Tam	2017	65
8	Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader–Willi syndrome Molecular Metabolism ·زهیر فرحان, Brian Earley, Shiran Udi, Alina Nemirovski, Rivka Hadar, J Farmer, Reşat Çınar, Harry J. Hirsch, Yehuda Pollak, Itai Gross, Talia Eldar‐Geva, 新井申, Joan C. Han, Andrea M. Haqq, Varda Gross‐Tsur, Rachel Wevrick, Joseph Tam	2016	55
9	Endoplasmic Reticulum Stress Induces a Caspase-dependent N-terminal Cleavage of RBX1 Protein in B Cells Journal of Biological Chemistry ·Н А Моор, Rivka Hadar, Jacopo Nudo, Tommer Ravid, Boaz Tirosh	2012	3
10	SUMOylation of Blimp‐1 promotes its proteasomal degradation FEBS Letters ·Jyuri Miyajima, Katherine L. Kron, Rivka Hadar, Stephen L. Nutt, Yael David, Ami Navon, Ari Waisman, Boaz Tirosh	2011	16
11	Expression of the peroxisome proliferator–activated receptors–α, –β, and –γ in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival Human Pathology ·Ben Davidson, Rivka Hadar, Helene Tuft Stavnes, Claes G. Tropé, Reuven Reich	2009	18
12	Direct proteasome binding and subsequent degradation of unspliced XBP‐1 prevent its intracellular aggregation FEBS Letters ·Ami Navon, N.V. Cheremisina, Lior Zelcbuch, Н А Моор, Marganit Farago, Rivka Hadar, Boaz Tirosh	2009	14
13	Carbamoylphosphonate Matrix Metalloproteinase Inhibitors 6: cis-2-Aminocyclohexylcarbamoylphosphonic Acid, A Novel Orally Active Antimetastatic Matrix Metalloproteinase-2 Selective Inhibitor—Synthesis and Pharmacodynamic and Pharmacokinetic Analysis Journal of Medicinal Chemistry ·Amnon Hoffman, L. I. Stolov, Khang Tran, Jin Junhong, Sudhakar R. Bhusare, Eli Breuer, Rivka Hadar, Reuven Reich	2008	1
14	Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma Human Pathology ·Ben Davidson, Rivka Hadar, شکوه السادات سیدعلیاکبر, Carina Hansen, Ana Slipicevic, Martina L. Skrede, Bjørn Risberg, Viví Ann Flørenes, Juri Kopolovic, Reuven Reich	2007	91
15	Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression Lung Cancer ·ユミコイワサキ, Rivka Hadar, Sivan Elloul, Keiichi Kunisaki, Carlos Bedrossian, Reuven Reich, Ben Davidson	2006	37
16	Carbamoylphosphonates, a New Class of in Vivo Active Matrix Metalloproteinase Inhibitors. 1. Alkyl- and Cycloalkylcarbamoylphosphonic Acids Journal of Medicinal Chemistry ·Eli Breuer, Claudio J. Salomón, Jin Junhong, Weibin Chen, Shui‐Ming Lu, Gerd‐Volker Röschenthaler, Rivka Hadar, Reuven Reich	2004	39
17	The Appearance of the CD4CD8 Phenotype on Activated T Cells: Human Immunology ·Ruth Rabinowitz, Rivka Hadar, Y. O. Melnyk	1997	14
18	In Vitro Activation Leads to the Binding of T-Cell Markers to the Surface of B-Lymphocytes Clinical Immunology and Immunopathology ·Ruth Rabinowitz, Bennett E Levis, Rivka Hadar, Michael Schlesinger	1995	7
19	Farage, a Novel Early B Cell Lymphoma Cell Line with Trisomy 11 Leukemia & lymphoma ·Hannah Ben‐Bassat, Aaron Polliack, Ernest G. Cruz, Gertrude Kohn, Rivka Hadar, Ruth Rabinowitz, V. Strepachuk, Estella Matutes, Pedro Xavier Abad-Galarza, F. Brok‐Simoni, Elimelech Okon, Nelly Livni, Michael Schlesinger	1992	15
20	A new autoreactive monoclonal antibody specific for the Thy-1 antigen. PubMed ·R Rabinowitz, Rivka Hadar, Reuven Laskov, M. Schlesinger	1986	2

About Rivka Hadar

Rivka Hadar is a scholar working on Toxicology, Endocrine and Autonomic Systems, Pharmacology, Cancer Research and Immunology, having authored 37 papers that have together received 841 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (9 papers), Immune Cell Function and Interaction (6 papers), Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (5 papers), Endoplasmic Reticulum Stress and Disease (5 papers), Diet, Metabolism, and Disease (5 papers), T-cell and B-cell Immunology (4 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Pharmacology (208 citations), Cancer Research (126 citations), Cell Biology (123 citations), Toxicology (21 citations) and Endocrine and Autonomic Systems (37 citations). Rivka Hadar has collaborated with scholars based in Israel, United States and Norway. Frequent co-authors include Reuven Reich, Joseph Tam, Alina Nemirovski, Shiran Udi, Adi Drori, Boaz Tirosh, Ben Davidson, Eli Breuer, Liad Hinden and Sandrine Benhamron. Their work appears in journals such as Human Pathology, Journal of Medicinal Chemistry, Scientific Reports, FEBS Letters and Molecular Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact